Shin gwajin MRD ya zama dole ga masu fama da cutar kansar huhu?

MRD (Ƙaramin Ciwon Rago), ko kuma Ƙananan Ciwon Rago, ƙaramin adadin ƙwayoyin cutar kansa ne (ƙwayoyin cutar kansa waɗanda ba sa amsawa ko kuma ba sa jure magani) waɗanda ke nan a jiki bayan maganin cutar kansa.
Ana iya amfani da MRD a matsayin alamar alama, tare da sakamako mai kyau ma'ana cewa har yanzu ana iya gano ragowar raunuka bayan maganin ciwon daji (ana gano ƙwayoyin cutar kansa, kuma ragowar ƙwayoyin cutar kansa na iya yin aiki kuma su fara ninkawa bayan maganin ciwon daji, wanda ke haifar da sake dawowar cutar), yayin da mummunan sakamako yana nufin cewa ba a gano ragowar raunuka bayan maganin ciwon daji ba (ba a sami ƙwayoyin cutar kansa ba);
Sanannen abu ne cewa gwajin MRD yana taka muhimmiyar rawa wajen gano marasa lafiya da ke fama da cutar kansar huhu ta hanyar ƙwayoyin cuta marasa ƙanana (NSCLC) waɗanda ke cikin haɗarin sake dawowa da kuma jagorantar maganin adjuvant bayan tiyata mai tsanani.
Yanayin da za a iya amfani da MRD:

Don ciwon daji na huhu da za a iya yi a farkon matakin farko

1. Bayan an yi wa marasa lafiya da ke fama da cutar kansar huhu tiyatar farko, yanayin MRD yana nuna cewa akwai babban haɗarin sake dawowa kuma yana buƙatar kulawa ta kusa. Ana ba da shawarar a riƙa sa ido kan MRD duk bayan watanni 3-6;
2. Ana ba da shawarar a gudanar da gwaje-gwajen asibiti na ciwon daji na huhu wanda ba ƙaramin ƙwayar halitta ba ne wanda za a iya yi a lokacin tiyata bisa ga MRD, kuma a samar da zaɓuɓɓukan magani daidai gwargwado gwargwadon iko;
3. Ba da shawarar a binciki rawar da MRD ke takawa a cikin nau'ikan marasa lafiya guda biyu, masu dauke da kwayar halittar direba da kuma marasa dauke da kwayar halittar direba, daban.

Ga ciwon huhu na ƙwayoyin halitta wanda ya ci gaba a yankin ba ƙaramin ƙwayar halitta ba

1. Ana ba da shawarar gwajin MRD ga marasa lafiya da ke cikin cikakkiyar sassauci bayan maganin chemotherapy mai ƙarfi don ciwon huhu na ƙananan ƙwayoyin halitta wanda ya ci gaba a yankin, wanda zai iya taimakawa wajen tantance hasashen da kuma tsara ƙarin dabarun magani;
2. Ana ba da shawarar gwaje-gwajen asibiti na maganin haɗin gwiwa bisa ga MRD bayan maganin chemotherapy don samar da zaɓuɓɓukan maganin haɗin gwiwa daidai gwargwadon iko.
Ga ciwon huhu na zamani wanda ba ƙaramin ƙwayar halitta ba ne
1. Akwai rashin nazarin da ya dace game da MRD a cikin ciwon daji na huhu wanda ba ƙaramin ƙwayar halitta ba ne;
2. Ana ba da shawarar a gano MRD a cikin marasa lafiya da ke cikin cikakkiyar sassauci bayan an yi musu magani na yau da kullun don ci gaba da cutar kansar huhu ba ta ƙananan ƙwayoyin halitta ba, wanda zai iya taimakawa wajen tantance hasashen da kuma tsara ƙarin dabarun magani;
3. Ana ba da shawarar yin bincike kan dabarun maganin MRD ga marasa lafiya a cikin cikakkiyar sassauci don tsawaita lokacin cikakkiyar sassauci gwargwadon iko ta yadda marasa lafiya za su iya ƙara yawan fa'idodin su.

Za a iya ganin cewa saboda rashin bincike mai dacewa kan gano MRD a cikin ciwon daji na huhu wanda ba ƙaramin ƙwayar halitta ba ne, ba a bayyana takamaiman amfani da gano MRD a cikin maganin marasa lafiya da suka kamu da ciwon daji na huhu waɗanda ba ƙaramin ƙwayar halitta ba.
A cikin 'yan shekarun nan, ci gaban da aka samu a fannin maganin da aka yi niyya da kuma na rigakafi ya kawo sauyi ga hasashen magani ga marasa lafiya da ke fama da cutar NSCLC mai ci gaba.
Shaidun da ke fitowa sun nuna cewa wasu marasa lafiya suna samun rayuwa ta dogon lokaci kuma ana sa ran za su sami cikakkiyar gafara ta hanyar ɗaukar hoto. Saboda haka, a ƙarƙashin ra'ayin cewa wasu ƙungiyoyin marasa lafiya da ke fama da cutar NSCLC mai ci gaba sun fahimci manufar rayuwa ta dogon lokaci a hankali, sa ido kan sake dawowar cututtuka ya zama babban batu na asibiti, kuma ko gwajin MRD zai iya taka muhimmiyar rawa a ciki ya cancanci a bincika shi a cikin ƙarin gwaje-gwajen asibiti.